The ostomy devices market has seen considerable growth due to a variety of factors.
• The market size of ostomy devices has consistently expanded in the past few years. There will be a surge from $2.8 billion in 2024 to $2.93 billion in 2025, displaying a compound annual growth rate (CAGR) of 4.8%.
Factors contributing to the growth during the historic period include a high occurrence of gastrointestinal disorders, rising number of colorectal cancer cases, advances in surgical procedures, improved quality of ostomy products, increased awareness and patient education, along with favorable healthcare policies.
The ostomy devices market is expected to maintain its strong growth trajectory in upcoming years.
• In the ensuing years, the ostomy devices market is predicted to experience substantial growth, anticipated to reach $3.56 billion in 2029, with a compound annual growth rate (CAGR) of 5.0%.
The expansion during the forecast period can be credited to factors such as an increasing aging populace and prevalence of chronic illnesses, development of patient-centric products, advances in materials and design, international growth of ostomy care cognizance, remote patient monitoring and telehealth, and modernization of healthcare systems. Key trends during the forecast period are expected to be eco-friendly products, customization and individualization, campaigns for awareness and education, containment of healthcare costs, and global market growth and accessibility.
The anticipated growth of the ostomy device market is largely because of the frequent incidence of colorectal cancer. The cancer, which forms in the colon or rectum tissues, involves the uncontrolled multiplication of abnormal cells in the lining of these organs, creating tumors that may invade other body parts if not promptly treated. An increased number of colorectal cancer instances necessitates a rise in ostomy surgeries. Ostomy devices are key in helping colorectal cancer patients post-surgery, allowing for efficient waste collection and management of bodily functions via attachment to the stoma. For instance, the American Cancer Society reported in January 2023 that colorectal cancer cases had risen from 149,500 in 2021 to 153,020 cases in 2023, marking a growth rate of 2.35%. Hence, the ostomy device market is likely to expand due to the high prevalence of colorectal cancer. The continuous increase in urology disease cases is likely to foster the ostomy devices market's growth. Urological conditions encompass health complications impacting the urinary and male reproductive systems. Ostomy devices play a pivotal role in handling particular urological disorders or complications by redirecting urine from the bladder or urinary tract. For instance, the Centers for Disease Control and Prevention (CDC) reported in May 2024 that approximately 14% of U.S. adults, or close to 35.5 million individuals, are thought to have chronic kidney diseases. Thus, the increasing prevalence of urological disorders is fueling the growth of the ostomy devices market.
The ostomy devices market covered in this report is segmented –
1) By Product: Bags, Accessories
2) By System Type: One-Piece System, Two-Piece System
3) By Surgery Type: Colostomy, Urostomy, Ileostomy
4) By End Users: Ambulatory Surgical Centers, Hospitals, Home Care, Other End-Users
Subsegments:
1) By Bags: Colostomy Bags, Ileostomy Bags, Urostomy Bags
2) By Accessories: Skin Barriers, Adhesives And Pastes, Deodorants And Cleansing Products, Belts And Support Garments
Companies that have a significant footprint in the ostomy device market are leveraging advanced materials that are friendly to human skin. This approach is designed to lower the chances of skin-related complications that may result from an extended duration of device contact. By incorporating these non-irritant compounds into ostomy devices, the manufacturers aim to reduce skin irritation, allergic reactions, and discomfort caused by long-term use of such devices. For instance, onvatec Group plc, a company based in the UK that deals in medical products and technologies, unveiled the Esteem Body with Leak Defense in February 2024. This new soft convex ostomy system (a one-piece design) aims to elevate patients' comfort levels and quality of care. It addresses major issues faced by individuals using ostomy devices, especially considering the increasing worldwide rates of obesity. The unique one-piece model includes advanced adhesives and can adapt to different body types, significantly diminishing leakage risk, a prevalent concern among users. Moreover, the system showcases a modern 8-shaped pouch design that resists sagging, constructed from water-resistant materials for discrete use in activities such as swimming.
Major companies operating in the ostomy devices market report are:
• 3M Company
• Henkel AG And Co. KGaA
• Avery Dennison Corporation
• B. Braun Melsungen AG
• Smith & Nephew PLC
• Coloplast Corp.
• ConvaTec Group PLC
• Hollister Incorporated
• Porex Corporation
• Perma-Type Company Inc.
• Dansac UK
• Salts Healthcare
• Zhejiang Longterm Medical Technology Co. Ltd.
• Vonco Products LLC
• Angiplast Pvt. Ltd.
• Scapa Healthcare Ltd.
• Welland Medical Limited
• Flexicare (Group) Limited
• Marlen Manufacturing And Development Company
• Advacare Pharma USA LLC.
• Nu-Hope Laboratories Inc.
• Torbot Group Inc.
• Genairex Inc.
• ALCARE Co. Ltd.
• OxMed International GmbH
• Cymed Inc.
• Schena Ostomy Technologies Inc.
• Sarasota Medical Products
• Safe N' Simple LLC
• Wuhan Sitaili Medical Apparatus Development Co. Ltd
North America was the largest region in the ostomy devices market in 2024. The regions covered in the ostomy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa